the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Arbitration (Amendment) Bill 2024 tabled for first reading

KUALA LUMPUR: The Arbitration (Amendment) Bill 2024, which aims to enhance Malaysia’s standing amongst the international arbitration community by improving the organisational structure of the Asian International Arbitration Centre (AIAC), was tabled for its first reading in the Dewan Rakyat today.

The bill, which seeks to amend the Arbitration Act 2005 (Act 646), was tabled by the Minister in the Prime Minister’s Department (Law and Institutional Reform) Datuk Seri Azalina Othman Said.

According to the bill uploaded on the Parliament’s website, amendments to Act 646 were in line with the execution of the Supplementary Agreement between the Government of Malaysia and the Asian-African Legal Consultative Organisation relating to the AIAC in Kuala Lumpur.

It also proposes several new sections related to third-party funding, including Section 46c, which seeks to provide that the rule of common law against maintenance and champerty shall cease to apply in relation to the third-party funding of arbitration and that a third-party funding agreement shall not be treated as contrary to public policy on the grounds of maintenance and champerty.

“With this provision, third-party funding of arbitration and court proceedings in respect of an arbitration shall no longer be prohibited in Malaysia,” according to the bill.

Meanwhile, Azalina also tabled the Construction Industry Payment and Adjudication (Amendment) Bill 2024 for its first reading, which seeks to provide for the name change of the Kuala Lumpur Regional Centre for Arbitration to AIAC.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings